## Secondary Osteosarcoma in Retinoblastoma Survivors **Key Point:** Osteosarcoma is the most common secondary malignancy in long-term survivors of hereditary retinoblastoma, particularly in patients treated with radiation therapy. The risk is 500–1000 times higher than in the general population. ### Pathogenesis of Secondary Osteosarcoma 1. **Germline RB1 mutation** — hereditary retinoblastoma patients carry a constitutional inactivation of the RB tumor suppressor gene. 2. **Two-hit mechanism** — radiation therapy (or chemotherapy) induces a second somatic mutation in osteoblasts within the radiation field. 3. **Latency period** — secondary osteosarcomas typically appear 5–20 years after initial treatment (median ~10 years). 4. **Field effect** — any bone in the radiation field is at risk; proximal humerus, femur, tibia, and pelvis are common sites. **High-Yield:** The combination of **hereditary retinoblastoma + radiation therapy = very high risk of osteosarcoma**. This is a classic NEET PG question linking genetic predisposition to secondary malignancy. ### Secondary Malignancies in Retinoblastoma Survivors | Malignancy | Frequency | Risk Factors | Notes | | --- | --- | --- | --- | | **Osteosarcoma** | Most common | Radiation to bone; RB1 germline mutation | Peak: 5–20 years post-treatment | | **Soft tissue sarcoma** | Second most common | Radiation to soft tissues | Fibrosarcoma, leiomyosarcoma | | **Melanoma** | Third | Radiation to skin; genetic predisposition | Increased risk in pineal region | | **Lung cancer** | Fourth | Radiation to chest; smoking | Late onset (>20 years) | | **Ewing sarcoma** | Rare | Radiation to bone (less common than OS) | Not the most common bone malignancy | **Clinical Pearl:** Retinoblastoma survivors require lifelong surveillance with imaging (MRI of the extremities, chest X-ray) and clinical examination. Any new bone pain or swelling in a survivor should raise suspicion for secondary osteosarcoma. ### Mnemonic: "**RB-OS**" (Retinoblastoma → Osteosarcoma) - **R**etinoblastoma (germline RB1 mutation) - **B**one (radiation to bone) - **O**steosarcoma (most common secondary malignancy) - **S**urvivors (long-term survivors at highest risk) **Warning:** Do not confuse secondary osteosarcoma with primary osteosarcoma in adolescents. Secondary osteosarcoma occurs in an older age group (typically 20s–30s in retinoblastoma survivors) and is associated with a history of prior malignancy and radiation. Primary osteosarcoma peaks in the teenage years without prior malignancy.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.